Batz W., Wunderlich W. (1976) Structural transformation of the Stefanidou M., Alevisopoulos G., Maravelias C., Loutsidis C., phagosomal membrane in Tetrahymena cells endocytosing Koutselinis A. (1999) Phagocytosis of the protozoon Tetra- latex beads. Arch. Microbiol. 109: 215–220
hymena pyriformis as an endpoint in the estimation of co- Baumert U., Vosskühler C., Tiedtke A. (1998) Formation and caine salt and cocaine freebase toxicity. Addiction Biology 4:
maturation of phagosomes labeled by magnetic micro par- ticles: an ultrastructural study in Tetrahymena thermophila. Stefanidou M., Georgiou M., Maravellas C., Koutselinis A. Eur. J. Protistol. 34: 291–300
(1990) The effects of morphine, cocaine, amphetamine, and Campbell N. A., Reece J. B., Simon E. J. (2008) “The Immune hashish on the phagocytosis of the protozoan Tetrahymena System.” Biology. 8th ed. Boston, MA: Pearson. 930–953 pyriformis (strain W). Toxic. In Vitro 4: 779–781
Carlson B. B., Trevitt J. T., Salamone J. D. (2000) Effects of H1 Wong D. T., Bymaster F. P., Engleman E. A. (1995) Prozac antagonists on cholinomimetic induced tremulous jaw move- (fluoxetine, lilly 110140), the first selective serotonin uptake ments: studies of diphenhydramine, doxepin, and mepyra- inhibitor and an antidepressant drug: twenty years since its mine. Pharm. Biochem. and Behavior 64: 683–689
first publication. Life Sciences 57: 411–441
Chiesa R., Silva W. I., Renaud F. L. (1993) Pharmacological char- Zar J. (2010). Biostatistical Analysis. 5th ed., Prentice Hall Inc., acterization of an opiod receptor in Tetrahymena. J. Eud. Mi- crobiol. 40: 800–804
Csaba G., Darvas Z. (1992) Insulin antagonizes the phagocytosis stimulating action of histamine in Tetrahymena. Bioscience Reports 12: 23–27
Csaba G., Darvas Z., Laszlo V. (1983) A functional study of con- canavalin A-histamine binding site overlap in Tetrahymena phagocytosis test. Comp. Biochem. Physiol. A. Comp. Physi- ol. 75: 457–460
Csaba G., Lantos T. (1973) Effect of hormones on protozoa. Studies on the phagocytotic effect of histamine, 5-hydroxyr- typtamine and indoleacetic acid in Tetrahymena pyriformis. Cytobiologie 7: 361
Csaba G., Laszlo V., Darvas Z. (1978) Effects of H1 and H2 re- ceptor antagonists on Tetrahymena. Acta Biol. Med. Ger. 37:
Darvas Z., Csaba G. (1981) Effect of histamine and histamine antagonists on the glycogen content of Tetrahymena. Acta Physiol. Acad. Sci. Hung. 58: 9–14
De Jesus S., Renaud F. L. (1989) Phagocytosis in Tetrahymena thermophila: naloxone-reversible inhibition by opiates. Comp. Biochem. Physiol. 92C: 139–142
Kovacs P., Csaba G. (1980) Detection of histamine binding sites (receptors) in Tetrahymena by fluorescence technique. Acta Biol. Med. Ger. 39: 237–241
Kovacs P., Darvas Z., Csaba G. (1981) Investigation of hista- mine-antihistamine differentiation ability of Tetrahymena receptors, by means of lectins and antihistamine antibodies. Acta Biol. Acad. Sci. Hung. 23: 111–117
Kovacs K., Kohidai L., Pallinger E., Csaba G. (2002) Effect of oxytocin and its analogues on phagocytosis of Tetrahymena: outstanding impact of isotocin. Acta Protozool. 41: 191–197
Kovacs P., Sunderman C. A., Csaba G. (1996) Investigation of receptor-mediated phagocytosis by hormone-induced (im- printed) Tetrahymena pyriformis. Experimentia 52: 769–773
Moya C. E., Jacobs R. S. (2006) Pseudopterosin A inhibits phago- cytosis and alters intracellular calcium turnover in a pertussis toxin sensitive site in Tetrahymena thermophila. Comp. Bio- chem. Physiol. 143: 436–443
Orias E. (1998) Mapping the germline and somatic genomes of a ciliated protozoan, Tetrahymena thermophila. Genome Res. 8: 91–99
Quinn G. P., Keough M. J. (2003) Experimental Design and Data Analysis for Biologists. Cambridge Press, New York, 537 pp.
Quinones-Maldonado V., Renaud F. L. (1987) Effect of biogenic amines on phagocytosis in Tetrahymena thermophila. J. Pro- tozool. 34: 435–438
Renaud F. L., Chiesa R., Rodriguez F., Tomassini N., Marino M. (1996) Studies on the opioid mechanism in Tetrahymena. Prog. Mol. Subcell. Biol. 17: 29–39
Rosner B. N., Bartholomew J. N., Gaines C. D., Riddle M. L., Ev- erett, H. A., Rulapaugh K. G., Nickerson L. E., Marshall M. R., Kuruvilla H. G. (2003) Biochemical evidence for a P2Y- like receptor in Tetrahymena thermophila. J. Comp. Physiol. A 189: 781–789

Source: http://www.ejournals.eu/resources/articles/acta11.pdf

Much of this material is cited from the web page www

Much of this material is cited from the web page What is low-dose naltrexone and why is it important? > Low-dose naltrexone holds great promise for the millions of people worldwide with autoimmune diseases or central nervous system disorders or who face a deadly cancer. Naltrexone itself was approved by the FDA in 1984 in a 50mg dose for the purpose of helping heroin or opium ad

Memo to: rick mumford, dds, mph

North Carolina Department of Health and Human Services Division of Public Health July 9, 2013 ( 2 pages – Replaces version posted August 3, 2012 ) To: All North Carolina Health Care Providers From: Megan Davies, MD, State Epidemiologist Re: Human infections with variant influenza H3N2v This memo is intended to provide information to North Ca

Copyright © 2014 Articles Finder